EAHP EU Monitor 19 November 2012
The EAHP EU Monitor is a weekly round up of news relevant to hospital pharmacy in Europe.
You can subscribe to receive the EAHP EU Monitor by email here.
|
Shortlist of abstract posters announced for 18th Congress of the EAHP
|
|
Pharma industry issue statement of caution on clinical trial transparency
|
European Parliament set conditions for approving Tonio Borg as new Health Commissioner
Before approving Tonio Borg as the new Health Commissioner of the European Union, Members of the European Parliament are requiring he agree to a set of conditions. Borg, Malta's deputy Prime Minister and Foreign Minister, was questioned for three hours by three of the Parliament’s Committees: the Health Committee, the Internal Market Committee and the Agriculture Committee. The political groups of the Parliament are currently divided on whether to support his candidacy with some groups (ALDE, Green/EFA, GUE/NGL) so far withholding their support based on concerns about his previously expressed opinions on homosexuality, divorce, abortion, and the scientific use of tissues and cells. In discussions, the European Parliament’s Political Group leaders have set out a list of conditions Mr Borg should meet before being approved to take over the European Commission’s Health Directorate. These are:
If Mr Borg agrees to these conditions, it is likely he will be ratified as the new EU Health Commissioner this week. More information about the hearing and procedure here |
|
|
EJHP: Implications of the EU Directive on prevention from sharp injuries in the hospital and healthcare sector on procurement decisions
An article was published this week on the online first section of the European Journal of Hospital Pharmacy (EJHP) about the impact of the EU Directive on prevention from sharp injuries in the hospital and healthcare sector on procurement decisions. Authored by Mark Santillo of the Department of Quality Assurance, South Devon Healthcare NHS Trust, England, the article considers the under-reporting of needle stick injuries and the risk such injuries pose in relation to infection from blood borne pathogens such as hepatitis B, C and HIV. The article summarises the main impacts for practice arising from the 2010 Directive on prevention from sharp injuries in the hospital and healthcare sector and what it means for procurement of a range of common injectables in the hospital setting including Low molecular weight heparins, Fragmin, Innohep and Clexane. The full article is available here |